In May 2018, I asked CervicalCheck to make the necessary arrangements to provide that any woman who had had a CervicalCheck smear test, and whose GP considered that she should have a further test as part of her reassurance, to access such a further test without charge. This decision was made in good faith to address the considerable fears of the many anxious women in Ireland, following issues which had emerged in relation to the CervicalCheck screening programme.
In the months since then, there has been a significant increase in the volume of women presenting for smear tests. This includes women who have availed of the out of cycle tests, but also a greater number of women presenting for scheduled screening. This increased level of engagement with the programme is very welcome. However, the increased demand has undoubtedly put pressure on lab capacity and turnaround times.
The HSE has been working actively with the labs to manage this issue and to improve turnaround times for smear tests. In addition, the HSE is aiming to source additional screening capacity, which would improve the turnaround time of results; however, sourcing capacity and resources is a global challenge as countries start to move to primary HPV screening, which vastly reduces the requirement for cytology screening staff. The HSE is currently developing a capacity plan, which will take account of available capacity and expected demand, with the aim of bringing the programme into stabilisation this year. This is a priority concern for my Department and the HSE.
In relation to the specific data requested, I have asked the HSE to respond directly to the Deputy.